Home
About CFCF
Board of Directors
Board of Patient Advisors
Board of Scientific Advisors
Carcinoid
Donations

Friends of CFCF

Fundraising Events

How You Can Help

Memorials

News
Photo Gallery

Research

CFCF Research Approach

CFCF Research Grants

CFCF Research Education


Sunflower

  Contact Us

  Search

Caring for Carcinoid Foundation - Genetic Research Paradigm

Genetic Research Paradigm

All carcinoid research supported by the Caring for Carcinoid Foundation (CFCF) is based on the new genetic research paradigm.

The genetic research paradigm enables scientists to discover a cure for cancer by unlocking its genetic causes, then developing novel, targeted therapies.

In the past, scientists had to take “blind aim” at treating cancer because they lacked a genetic understanding of its causes.  Now, we live in a tremendously exciting time for cancer research due to the completion of the Human Genome Project in 2003.  This major advance in genetic knowledge has enabled scientists to study cancer—including carcinoid—at the level of individual genes and develop highly effective, targeted treatments.

The following presentation was prepared by the National Cancer Institute.  It provides an overview of the genetic research paradigm and why it is now possible to discover a cure for cancer, including carcinoid.

For further information, please review the references listed at the end.

Slide 1:  Genetic mutations lead to cancer

  • All cancer is genetic, in that it is triggered by altered genes.  Genes that control the orderly replication of cells become damaged, allowing the cells to reproduce without restraint.
  • Cancer usually arises in a single cell.  The cell’s progress from normal to malignant to metastatic appears to involve a series of distinct changes in the tumor and its immediate environment, and each is influenced by different sets of genes.


Click picture to enlarge

back to top
 

Slide 2:  What is a gene?

  • A gene is a working subunit of a DNA molecule.
  • A gene is any given segment along the DNA carrying a particular set of instructions that allows a cell to produce a specific product—typically, a protein such as an enzyme.  There are about 25,000 genes, and every gene is made up of thousands, even hundreds of thousands, of chemical bases.


Click picture to enlarge

back to top
 

Slide 3: What is DNA?

  • DNA is a vast chemical information database.  It resides in the core, or nucleus, of each of the body’s trillions of cells, and it carries the complete set of instructions for making all the proteins a cell will ever need.

Click picture to enlarge

back to top
 

Slide 4:  DNA à RNA à Protein

  • Building proteins lies at the heart of cell function.
  • For a cell to make a protein, the information from a gene is copied, base by base, from a strand of DNA into a strand of messenger RNA.  Messenger RNA travels out of the nucleus into the cytoplasm, to cell organelles called ribosomes.  There, messenger RNA directs the assembly of amino acids that fold into a completed protein molecule.


Click picture to enlarge

back to top
 

Slide 5:  Genetic mutations and disease

  • A sound body depends on the continuous interplay of thousands of proteins, acting together in just the right amounts and in just the right places—and each properly functioning protein is the product of an intact gene.
  • Many, if not most, diseases have their roots in our genes.  More than 4,000 diseases stem from altered genes inherited from one’s mother and/or father.  Common disorders such as heart disease and most cancers arise from a complex interplay among multiple genes and between genes and factors in the environment.


Click picture to enlarge

back to top
 

Slide 6:  Types of genetic mutations

  • Genes can be altered, or mutated, in many ways.
  • The most common gene change involves a single base mismatch—a misspelling—placing the wrong base in the DNA.  At other times, a single base may be dropped or added.  And sometimes large pieces of DNA are mistakenly repeated or deleted.


Click picture to enlarge

back to top
 

Slide 7:  Altered DNA à altered protein

  • When a gene contains a mutation, the protein encoded by that gene is likely to be abnormal.
  • Sometimes the protein will be able to function, but imperfectly.  In other cases, it will be totally disabled.  The outcome depends not only on how it alters a protein’s function but also on how vital that particular protein is to survival.


Click picture to enlarge

back to top
 

Slide 8:  Acquired mutations

  • Acquired mutations are changes in DNA that develop throughout a person’s lifetime.
  • Although mistakes occur in DNA all the time, especially during cell division, a cell has the remarkable ability to fix them.  But if DNA repair mechanisms fail, mutations can be passed along to future copies of the altered cell.


Click picture to enlarge

back to top
 

Slide 9:  Hereditary mutations

  • Gene mutations can be either inherited from a parent or acquired.
  • Hereditary mutations are carried in the DNA of the reproductive cells.  When reproductive cells containing mutations combine to produce offspring, the mutation will be in all of the offspring’s body cells.  The fact that every cell contains the gene change makes it possible to use cheek cells or a blood sample for gene testing.
  • Even though all cancer is genetic, just a small portion—perhaps 5 or 10 percent—is inherited.
  • Most cancers come from random mutations that develop in body cells during one’s lifetime—either as a mistake when cells are going through cell division or in response to injuries from environmental agents such as radiation or chemicals.


Click picture to enlarge

back to top
 

Slide 10:  Microarray analysis

  • Much of the excitement today centers on gene expression profiling that uses a technology called microarrays.  A DNA microarray is a thin-sized chip that has been spotted at fixed locations with thousands of single-stranded DNA fragments corresponding to various genes of interest.  A single microarray may contain 10,000 or more spots, each containing pieces of DNA from a different gene.  Fluorescent-labeled probe DNA fragments are added to ask if there are any places on the microarray where the probe strands can match and bind.  Complete patterns of gene activity can be captured with this technology.


Click picture to enlarge

back to top
 

Slide 11:  Human Genome Project

  • Identifying genes associated with disease—indeed, tracking down every chemical base in each of the estimated 25,000 genes as well as the spaces between them, a process called mapping the human genome—has been accomplished successfully by an international collaboration known as the Human Genome Project.
  • Scientists have developed a consensus sequence, laying out the order in which all the human genes sit along the chromosomes.  This information can be used to determine where gene mutations occur in specific diseases.  For example, here is a chart of disease-linked genes located along the X chromosome.


Click picture to enlarge

back to top
 

References

To learn more about the genetic research paradigm, the Caring for Carcinoid Foundation recommends the following websites:

Department of Energy - Office of Science

"The Department of Energy’s Office of Science founded the Human Genome Project and is a leader in systems biology research."

Website

National Cancer Institute

"The National Cancer Institute (NCI) is a component of the National Institutes of Health, one of eight agencies that compose the Public Health Service in the Department of Health and Human Services.  The NCI, established under the National Cancer Act of 1937, is the federal government’s principal agency for cancer research and training."

Website
Document, "Targeted Cancer Therapies:  Questions and Answers"

National Center for Biotechnology Information

"As a national resource for molecular biology information, the National Center for Biotechnology Information’s mission is to develop new information technologies to aid in the understanding of fundamental molecular and genetic processes that control health and disease."

Website

National Human Genome Research Institute

"The National Human Genome Research Institute (NHGRI) led the Human Genome Project for the National Institutes of Health, which culminated in the completion of the full human genome sequence in April 2003.  Now, the NHGRI moves forward into the genomic era with research aimed at improving human health and fighting disease."

Website
Document, "Genetics - The Future of Medicine"

back to top


   
Sign up for free CFCF E-Updates
Email:  
   

10 Ways to Help Now!


CFCF Profile

 


CFCF Headlines

 

CFCF Announces Partnership with Molecular Insight Pharmaceuticals

 

Dr. Matthew Kulke posts inaugural entry to CFCF Research Blog

 

Nancy O'Hagan appointed to Neuroendocrine Task Force of NCI Gastrointestinal Steering Committee

 

Dr. Arnold Levine joins

CFCF Board of Scientific Advisors

 

Dr. Evan Vosburgh joins
CFCF Board of Scientific Advisors

 

CFCF-funded researcher
Dr. Andrew Leiter published in Developmental Biology

 

CFCF launches Insider Pages online fundraiser

 

CFCF enters 2008 Seattle to Portland Bicycle Classic

 

Blackwood family launches
"Tri to Find a Cure for Carcinoid Cancer" Triathlon

 

Rose Colleran runs
Boston Marathon for CFCF

 

2008 Run for Hope open
for registration

 

Novartis launches new
clinical trial for metastatic carcinoid patients

 

SIRT Symposium on
May 2-3, 2008 in Chicago

 


CFCF QuickPoll

Visit CFCF QuickPoll archive


CFCF Doctor Database

CFCF Doctor Database

Carcinoid Treatment Centers


CFCF FAQ

Is it possible to cure carcinoid?

 

How long will it take to
cure carcinoid?

 

How much money will be needed to cure carcinoid?

 

Will achieving our mission benefit all carcinoid patients?


CFCF Fundraising

 

Join Team CFCF in
2008 Pan-Mass Challenge


Tell a Friend!


CFCF Sunflower E-Cards


Shop for CFCF

P.S. Prints sells sunflower
t-shirts, mugs, postcards, etc.


Copyright 2007 Caring for Carcinoid Foundation | All Rights Reserved | Privacy Policy | User Agreement | Site Map
One Kendall Square | PMB 180 | Cambridge, MA 02139 | (857) 222-5492 |